Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Dividends Paid - Preferred Dividends Paid - Preferred Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Lifecore Biomedical, Inc. \De\ (LFCR) Shares Issued (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Shares Issued over the past 13 years, most recently at $23.8 million for Q2 2025.

For Q2 2025, Shares Issued changed N/A year-over-year to $23.8 million; the TTM value through May 2025 reached $23.8 million, up 3194.2%, while the annual FY2025 figure was $23.8 million, 3194.2% up from the prior year.
Shares Issued for Q2 2025 was $23.8 million at Lifecore Biomedical, Inc. \De\, up from -$23.8 million in the prior quarter.
Over five years, Shares Issued peaked at $23.8 million in Q2 2025 and troughed at -$23.8 million in Q1 2025.
A 4-year average of $2.5 million and a median of $362500.0 in 2023 define the central range for Shares Issued.
Biggest five-year swings in Shares Issued: surged 3392.82% in 2024 and later crashed 3392.96% in 2025.
Year by year, Shares Issued stood at $5.0 million in 2022, then plummeted by 114.48% to -$724000.0 in 2023, then surged by 3392.82% to $23.8 million in 2024, then grew by 0.04% to $23.8 million in 2025.
Business Quant data shows Shares Issued for LFCR at $23.8 million in Q2 2025, -$23.8 million in Q1 2025, and $23.8 million in Q4 2024.